Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9bf8f8527cfdd7e1b25a4c8f3cca470 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6871 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6913 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2013-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04baa8013d271e66309dc160bc01283b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8646604b00e5394c548a55850a5a847b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57fe58ed1ceea628dca51eb60775c6c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00d06a176c03c99a1f63ca4740aa6c76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5295656a6f45a35aa177a40bcc414d79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8fa4cda3f1a3ca18300671e5e34eff8 |
publicationDate |
2018-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2013355337-B2 |
titleOfInvention |
Combination therapy for treating HER2-positive cancers |
abstract |
Methods for treating cancer patients with HER2-positive tumors are disclosed. The methods comprise administering to a patient a therapeutically effective amount of a combination of (i) an anthracycline-loaded immunoliposome with a targeting moiety that is a first anti-HER2 antibody and (ii) an anti-cancer therapeutic comprising a second anti-HER2 antibody. |
priorityDate |
2012-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |